KENNEDY BYRD DNP
Prescription History 1396148607
Nurse Practitioner - Acute Care in Salt Lake City, UT
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for KENNEDY BYRD DNP, an active Acute Care specialist practicing in Salt Lake City, UT. Our medical registry currently tracks 3 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 46 documented patient claims. Among these therapy options, the most frequently utilized medication is Oxycodone Hcl, which accounts for 19 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other UT PrescribersVs. UT Avg |
|---|---|---|---|
| Oxycodone Hcl | 19 | $18.92 | ▼ Less than typical |
About Oxycodone Hcl: This medication is used to help relieve moderate to severe pain. Show more ▾ Oxycodone belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain. A semisynthetic derivative of CODEINE. In 2024, this provider wrote 19 Medicare prescriptions for Oxycodone Hcl, about a third of the volume of the typical Utah prescriber of this medication (57.2). Medicare paid an average of $18.92 per fill, versus $17.36 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average UT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 19 30-Day Fills standardized to 30-day supplies 161 Days of Medication total across all patients in 2024 | |||
| XareltoRivaroxaban | 16 | $391.06▼ below UT avg | ▼ Less than typical |
About Xarelto: Rivaroxaban is used to prevent blood clots from forming due to a certain irregular heartbeat (atrial fibrillation) or after hip or knee replacement surgery. Show more ▾ It is also used to prevent blood clots from forming in high-risk patients with limited mobility during their hospital stay and after discharge. In addition, rivaroxaban is used to treat blood clots (such as in deep vein thrombosis-DVT or pulmonary embolus-PE) and to prevent the blood clots from forming again. Rivaroxaban may be used in children to prevent blood clots from forming after a certain heart surgery (Fontan procedure). Rivaroxaban is an anticoagulant that works by blocking certain clotting proteins in your blood. A morpholine and thiophene derivative that functions as a FACTOR XA INHIBITOR and is used in the treatment and prevention of DEEP-VEIN THROMBOSIS and PULMONARY EMBOLISM. It is also used for the prevention of STROKE and systemic embolization in patients with non-valvular ATRIAL FIBRILLATION, and for the prevention of atherothrombotic events in patients after an ACUTE CORONARY SYNDROME. In 2024, this provider wrote 16 Medicare prescriptions for Xarelto, about half the volume of the typical Utah prescriber of this medication (37.6). Medicare paid an average of $391.06 per fill, versus $1,016.76 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average UT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the UT average for this medication. 18 30-Day Fills standardized to 30-day supplies 325 Days of Medication total across all patients in 2024 | |||
| Clonazepam | 11 | $14.00 | ▼ Less than typical |
About Clonazepam: Clonazepam is used to prevent and control seizures. Show more ▾ This medication is known as an anticonvulsant or antiepileptic drug. It is also used to treat panic attacks. Clonazepam works by calming your brain and nerves. It belongs to a class of drugs called benzodiazepines. An anticonvulsant used for several types of seizures, including myotonic or atonic seizures, photosensitive epilepsy, and absence seizures, although tolerance may develop. It is seldom effective in generalized tonic-clonic or partial seizures. The mechanism of action appears to involve the enhancement of GAMMA-AMINOBUTYRIC ACID receptor responses. In 2024, this provider wrote 11 Medicare prescriptions for Clonazepam, about a quarter of the volume of the typical Utah prescriber of this medication (42). Medicare paid an average of $14.00 per fill, versus $9.70 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average UT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 11 30-Day Fills standardized to 30-day supplies 237 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for KENNEDY BYRD DNP is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Acute Care prescribing approach at this Salt Lake City, UT practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among UT prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
